Metformin-associated Lactic Acidosis with Hypoglycemia during the COVID-19 Pandemic.
Intern Med
; 61(15): 2333-2337, 2022 Aug 01.
Article
in English
| MEDLINE | ID: covidwho-1968927
ABSTRACT
Metformin-associated lactic acidosis (MALA) is an extremely rare but life-threatening adverse effect of metformin treatment. The lifestyle changes associated with the coronavirus disease 2019 (COVID-19) pandemic may increase the potential risk of MALA development in patients with diabetes. We herein report a 64-year-old Japanese man taking a small dose of metformin who presented with MALA accompanied by hypoglycemia secondary to increased alcohol consumption triggered by lifestyle changes during the pandemic. Physicians should prescribe metformin judiciously to prevent MALA development and pay close attention to lifestyle changes in patients at risk for MALA during the COVID-19 pandemic.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Acidosis, Lactic
/
Diabetes Mellitus, Type 2
/
COVID-19
/
Hypoglycemia
/
Metformin
Type of study:
Case report
/
Prognostic study
Topics:
Long Covid
Limits:
Humans
/
Male
/
Middle aged
Language:
English
Journal:
Intern Med
Journal subject:
Internal Medicine
Year:
2022
Document Type:
Article
Affiliation country:
Internalmedicine.9179-21
Similar
MEDLINE
...
LILACS
LIS